MAIA Biotechnology logo
MAIA Biotechnology
MAIA | AMEX
Chart Builder DCF Calculator
$1.01
+$0.01 (+0.50%)
At close: Nov 16, 2026, 4:00 PM ET
$1.02
+$0.01 (+0.99%)
After-hours: Nov 16, 2026, 7:20 PM ET

MAIA Biotechnology Company Profile

Company profile explained

Company Profile

MAIA Biotechnology, Inc. is a clinical-stage biotech firm dedicated to discovering, developing, and commercializing treatments for various cancers, with a primary focus on non-small cell lung cancer. The company's leading experimental compound, THIO, is an investigational drug candidate that utilizes a unique dual mechanism by targeting telomeres and stimulating an immune response. Established in 2018, the enterprise maintains its headquarters in Chicago, Illinois.

Key Executives

Name Position
Vlad Vitoc Co-Founder, President, Chief Executive Officer & Chairman of the Board of Directors
Jeffrey C. Himmelreich Head of Finance and Principal Financial & Accounting Officer
Linda Moreira Company Secretary
Sergei Gryaznov Chief Scientific Officer

Latest SEC Filings

Date Type Title
Oct 07, 2026 424B3 Filing
Oct 06, 2026 EFFECT Filing
Oct 06, 2026 8-K Current Report
Oct 02, 2026 4 Filing
Oct 02, 2026 4 Filing
Oct 02, 2026 4 Filing
Oct 02, 2026 4 Filing
Oct 02, 2026 4 Filing
Oct 02, 2026 424B3 Filing
Oct 02, 2026 4 Filing
View All SEC Filings ➞
MAIA Biotechnology
MAIA Biotechnology logo
Country United States
IPO Date Jul 28, 2022
Industry Biotechnology
Sector Healthcare
Employees 13
CEO Vlad Vitoc

Contact Details

444 West Lake Street Chicago, Illinois 60606 United States

Stock Details

Ticker Symbol MAIA
Exchange AMEX
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001878313
CUSIP Number 552641102
ISIN Number US5526411021
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.